122 related articles for article (PubMed ID: 10362281)
1. Azelaic acid: potential as a general antitumoural agent.
Breathnach AS
Med Hypotheses; 1999 Mar; 52(3):221-6. PubMed ID: 10362281
[TBL] [Abstract][Full Text] [Related]
2. Hyperpigmentary disorders--mechanisms of action. Effect of azelaic acid on melanoma and other tumoral cells in culture.
Breathnach AS; Robins EJ; Nazzaro-Porro M; Passi S; Picardo M
Acta Derm Venereol Suppl (Stockh); 1989; 143():62-6. PubMed ID: 2672685
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines.
Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R
Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231
[TBL] [Abstract][Full Text] [Related]
4. Effect of dicarboxylic (C6 and C9) acids on a human squamous carcinoma cell line in culture.
Pätzold HC; Breathnach AS; Robins EJ; Daridan ME; Bhasin YP; Ethridge LB; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1989 Apr; 4(2):167-71. PubMed ID: 2520453
[TBL] [Abstract][Full Text] [Related]
5. Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%.
Vereecken P; Heenen M
Int J Clin Pract; 2002; 56(1):68-9. PubMed ID: 11831841
[TBL] [Abstract][Full Text] [Related]
6. Topographical analysis of proliferation ([3H]thymidine labelling index and mitotic index) as compared with tumour growth and tumour weight in xenotransplanted melanoma. Changes due to local and systemic application of azelaic acid.
Nüssgen AI; Fritz U; Graupe K; Breitbart EW; Schmiegelow P
Acta Derm Venereol Suppl (Stockh); 1989; 143():67-74. PubMed ID: 2773615
[TBL] [Abstract][Full Text] [Related]
7. [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures].
Geier G; Hauschild T; Bauer R; Kreysel HW
Hautarzt; 1986 Mar; 37(3):146-8. PubMed ID: 3700102
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
[TBL] [Abstract][Full Text] [Related]
9. Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture.
Breathnach AS; Robins EJ; Pätzold HC; Bhasin YP; Ethridge LB; Garner A; Nazzaro-Porro M
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):491-8. PubMed ID: 2925320
[TBL] [Abstract][Full Text] [Related]
10. [Effect of various chemotherapeutic agents on the synthesis and distribution of DNA in human strains of kidney and lung cancer, melanoma and Ewing's sarcoma transplanted to athymic mice].
Revazova ES; Petrova AS; Iudicheva TV; Zubrikhina TN
Biull Eksp Biol Med; 1981 Oct; 91(10):471-3. PubMed ID: 7317610
[No Abstract] [Full Text] [Related]
11. Azelaic acid: mode of action at cellular and subcellular levels.
Galhaup I
Acta Derm Venereol Suppl (Stockh); 1989; 143():75-82. PubMed ID: 2475996
[TBL] [Abstract][Full Text] [Related]
12. Azelaic acid.
Nazzaro-Porro M
J Am Acad Dermatol; 1987 Dec; 17(6):1033-41. PubMed ID: 2963038
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect.
Akiyama N; Hijikata M; Kobayashi A; Yamori T; Tsuruo T; Natori S
Anticancer Res; 2000; 20(1A):357-62. PubMed ID: 10769680
[TBL] [Abstract][Full Text] [Related]
14. The depigmenting effect of azelaic acid.
Nazzaro-Porro M; Passi S; Zina G; Breathnach AS
Arch Dermatol; 1990 Dec; 126(12):1649-51. PubMed ID: 2073286
[No Abstract] [Full Text] [Related]
15. A case of recurrent (following surgery x2) invasive malignant melanoma with satellitosis (stage IIIA) successfully resolving after azelaic acid treatment administered by several routes.
Nazzaro-Porro M; Breathnach AS; Balus L; Passi S; Picardo M; Potenza C
Clin Exp Dermatol; 1996 Jul; 21(4):321-3. PubMed ID: 8959915
[No Abstract] [Full Text] [Related]
16. Anticancer effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) against A549 non-small cell lung cancer cell line is related to its anti-invasive activity.
Shibata J; Murakami K; Wierzba K; Aoyagi Y; Hashimoto A; Sano M; Toko T; Yamada Y
Anticancer Res; 2000; 20(5A):3169-76. PubMed ID: 11062739
[TBL] [Abstract][Full Text] [Related]
17. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
19. [Dicarboxylic acids inhibit the growth of keratinocytes in vitro].
Detmar M; Müller R; Stadler R; Orfanos CE
Hautarzt; 1986 Nov; 37(11):625-7. PubMed ID: 3804734
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
